General News

South Africa to resume Johnson & Johnson jabs

Date: Apr 26, 2021

South Africa will resume its Johnson & Johnson COVID-19 vaccine rollout on Wednesday following recommendations from its cabinet and the health regulatory authority.

The authorities will however work "to ensure that there is intensified pre-vaccination assessment and post vaccination monitoring when the rollout is resumed", Health Minister Zweli Mkhize said.  

“It has since been established there is a one-in-a-million chance of getting the clot after the vaccine, and that it appears that women between the ages of 18 and 48 years old are particularly at risk.     

"With such a low probability of developing a clot, all the regulators across the world have recommended the continued use of Johnson and Johnson,"Mkhize said in a statement on Monday announcing the resumption.    

The number of vaccination sites will also be expanded across the country once the vaccination resumes. 

The country suspended its Johnson & Johnson vaccination programme two weeks ago over concerns that the jab could cause blood clots.


comments powered by Disqus

Web Content Viewer (JSR 286)

Complementary Content

Your Name:*

Your Email:*

Your Message:*

Enter Captcha:*